Legal Representation
Attorney
Gregory J. Chinlund
USPTO Deadlines
Next Deadline
174 days remaining
NOA E-Mailed - SOU Required
Due Date
June 16, 2026
Extension Available
Until December 16, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 16, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 22, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 7, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 7, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 7, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 7, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 19, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 19, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 19, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 19, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 19, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 10, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 10, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 10, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations and substances for the treatment of bone diseases and disorders; Pharmaceutical preparations and substances for the treatment of pathological calcification; Pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; Pharmaceutical preparations and substances for the treatment of kidney diseases and disorders
Classification
International Classes
005